The NGAL Test is a particle-enhanced turbidimetric immunoassay for the quantitative determination of NGAL in human urine and plasma on automated clinical chemistry analyzers. NGAL measurements are useful in the risk assesment of AKI.
NGAL - Bioporto
Elevated Neutrophil Gelatinase-Associated Lipocalin Is Associated With the Severity of Kidney Injury and Poor Prognosis of Patients With COVID-19 - ScienceDirect
News - Bioporto
About BioPorto - Bioporto
The Prognostic Utility of Plasma NGAL Levels in ST Segment Elevation in Myocardial Infarction Patients
Selected biochemical parameters in the urine of HIV-infected patients in monitoring of kidney function
NGAL - Bioporto
/wp-content/uploads/2023/12/ProNephro
BioPorto Submits Application for Marketing Authorization of NGAL Test to the US Food and Drug Administration
About BioPorto - Bioporto
PDF) Does NGAL reduce costs? A cost analysis of urine NGAL (uNGAL) & serum creatinine (sCr) for acute kidney injury (AKI) diagnosis
BioPorto Diagnostics A/S: Contact Details and Business Profile
NGAL - Bioporto
